Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000131657 | SCV000186684 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-06-05 | criteria provided, single submitter | clinical testing | The p.S238Y variant (also known as c.713C>A), located in coding exon 4 of the MSH6 gene, results from a C to A substitution at nucleotide position 713. The serine at codon 238 is replaced by tyrosine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV000656889 | SCV000279093 | uncertain significance | not provided | 2023-05-10 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 21437237) |
Counsyl | RCV000410793 | SCV000488368 | uncertain significance | Lynch syndrome 5 | 2016-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000472070 | SCV000551284 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000214572 | SCV000601613 | uncertain significance | not specified | 2016-11-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000131657 | SCV000690474 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-01 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with tyrosine at codon 238 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with an unspecified, Lynch syndrome-associated cancer (PMID: 31391288). This variant has been identified in 2/282376 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Institute for Clinical Genetics, |
RCV000656889 | SCV002010076 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000410793 | SCV004019057 | uncertain significance | Lynch syndrome 5 | 2023-03-29 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |
Baylor Genetics | RCV003467180 | SCV004197571 | uncertain significance | Endometrial carcinoma | 2024-02-18 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998114 | SCV004836863 | uncertain significance | Lynch syndrome | 2023-11-20 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with tyrosine at codon 238 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with an unspecified, Lynch syndrome-associated cancer (PMID: 31391288). This variant has been identified in 2/282376 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |